Source: Antimicrobial Agents Chemother. Unidade: IF
Subjects: BIOFÍSICA, LEISHMANIOSE VISCERAL, ESPALHAMENTO DE RAIOS X A BAIXOS ÂNGULOS, DOENÇAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA-SILVA, Thais Alves da et al. Nanoliposomal Buparvaquone Immunomodulates Leishmania (L.) infantum-infected Macrophages and is Highly Effective in Murine Model. Antimicrobial Agents Chemother, v. 61, n. 9, p. 1-45, 2017Tradução . . Disponível em: https://doi.org/10.1128/AAC.02297-16. Acesso em: 19 set. 2024.APA
Costa-Silva, T. A. da, Galisteo Junior, A. J., Lindoso, J. A. L., Barbosa, L. R. S., & Tempone, A. G. (2017). Nanoliposomal Buparvaquone Immunomodulates Leishmania (L.) infantum-infected Macrophages and is Highly Effective in Murine Model. Antimicrobial Agents Chemother, 61( 9), 1-45. doi:10.1128/AAC.02297-16NLM
Costa-Silva TA da, Galisteo Junior AJ, Lindoso JAL, Barbosa LRS, Tempone AG. Nanoliposomal Buparvaquone Immunomodulates Leishmania (L.) infantum-infected Macrophages and is Highly Effective in Murine Model [Internet]. Antimicrobial Agents Chemother. 2017 ; 61( 9): 1-45.[citado 2024 set. 19 ] Available from: https://doi.org/10.1128/AAC.02297-16Vancouver
Costa-Silva TA da, Galisteo Junior AJ, Lindoso JAL, Barbosa LRS, Tempone AG. Nanoliposomal Buparvaquone Immunomodulates Leishmania (L.) infantum-infected Macrophages and is Highly Effective in Murine Model [Internet]. Antimicrobial Agents Chemother. 2017 ; 61( 9): 1-45.[citado 2024 set. 19 ] Available from: https://doi.org/10.1128/AAC.02297-16